Mesa Labs SVP exercises options, gains RSU award
Mesa Laboratories executive Brian David Archbold reported compensation-related equity changes.
Rhea-AI Filing Summary
Mesa Laboratories executive Brian David Archbold reported compensation-related equity changes. On June 15, 2026, he exercised derivative awards to acquire 2,454 shares of Mesa Laboratories common stock at $104.08 per share, increasing his direct common stock holdings to 4,861 shares.
He also received a new grant of 4,328 Restricted Stock Units (RSUs), each representing one share of common stock, which vest in stages starting on June 15, 2026. In addition, 1,780 Non Qualified Stock Options with a $226.72 exercise price reached expiration.
Following these transactions, Archbold holds 4,328 RSUs and 11,852 Non Qualified Stock Options alongside his common shares, reflecting ongoing equity-based compensation rather than open-market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
2,454 shares exercised/converted
Exercise
4 txns
Insider
Archbold Brian David
Role
SVP Operations
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Derivative Expiration | Non Qualified Stock Options | 1,780 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units - 9 | 2,454 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units - 10 | 4,328 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,454 | $104.08 | $255K |
Holdings After Transaction:
Non Qualified Stock Options — 11,852 contracts (Direct);
Restricted Stock Units - 9 — 4,892 contracts (Direct);
Restricted Stock Units - 10 — 4,328 contracts (Direct);
Common Stock — 4,861 shares (Direct)
Footnotes (5)
- F1. NSOs that vested 1/3 on each anniversary date of the June 15, 2020 grant date
- F2. Each RSU represents a contingent right to receive one share of the Issuer's common stock
- F3. RSUs that vest 1/3 on June 15, 2026 and each of the next two anniversary dates
- F4. Not Applicable
- F5. RSUs that vest 34% on June 15, 2027, 33% on June 8, 2028 and 33% on June 8 2029
Key Figures
Common shares acquired via exercise: 2,454 shares at $104.08
Common shares held after transactions: 4,861 shares
New RSU grant: 4,328 RSUs
+3 more
6 metrics
Common shares acquired via exercise
2,454 shares at $104.08
Derivative exercise into Mesa Laboratories common stock on June 15, 2026
Common shares held after transactions
4,861 shares
Direct Mesa Laboratories common stock holdings following June 15, 2026 actions
New RSU grant
4,328 RSUs
Restricted Stock Units granted June 15, 2026, each for one common share
Options expired
1,780 options at $226.72
Non Qualified Stock Options reaching expiration on June 15, 2026
Options remaining after expiration
11,852 options
Total Non Qualified Stock Options held after expiration event
RSUs held after grant
4,328 RSUs
Total Restricted Stock Units outstanding following the new award
Key Terms
Restricted Stock Units, Non Qualified Stock Options, vest, exercise price, +1 more
5 terms
Restricted Stock Units financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Non Qualified Stock Options financial
"Non Qualified Stock Options with a $226.72 exercise price reached expiration"
vest financial
"RSUs that vest 1/3 on June 15, 2026 and each of the next two anniversary dates"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"Non Qualified Stock Options had a 226.7200 exercise price per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration financial
"Non Qualified Stock Options show an expiration date of June 15, 2026"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MESA LABORATORIES (MLAB) SVP Brian Archbold report on this Form 4?
Brian David Archbold reported equity compensation changes, including exercising derivative awards into 2,454 common shares, receiving 4,328 new RSUs, and the expiration of 1,780 stock options. These are internal compensation events, not open-market stock purchases or sales.
What Restricted Stock Units did MLAB grant to Brian Archbold on June 15, 2026?
Mesa Laboratories granted Brian Archbold 4,328 Restricted Stock Units on June 15, 2026. Each RSU represents a contingent right to receive one share of common stock, vesting in scheduled tranches over several years as described in the footnotes.
Which Mesa Laboratories stock options expired for Brian Archbold in this filing?
The filing shows 1,780 Non Qualified Stock Options expired on June 15, 2026 at an exercise price of $226.72 per share. These options were previously granted and had already vested according to the disclosed vesting schedule.
What equity awards does Brian Archbold still hold after this Mesa Laboratories filing?
After these transactions, Brian Archbold holds 4,861 common shares, 4,328 RSUs tied to common stock, and 11,852 Non Qualified Stock Options. These positions reflect ongoing participation in Mesa Laboratories’ long-term incentive and stock option programs.
AI-generated analysis. How Rhea-AI works. Not financial advice.
